Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial
Those who did not saw their results drop to around 13.6 percent
Campbell SA, Johnson J, Light PE
GLP-1 Drugs: Effective Tools, But They Do Not Rebuild the Metabolic System GLP-1 receptor agonists reduce hunger, slow gastric emptying and improve blood sugar regulation
Initially, incretin therapies focused on synthesizing GLP-1 analogues that were resistant to degradation by dipeptidyl peptidase-4 (DPP-4), which rapidly breaks down endogenous GLP-1 (Rhrborn et al., 2015)
This evolutionary mechanism essentially tells your body to travel to a different food source, and by the time your appetite returns, you'll be somewhere else